Commitments and Contingencies (Details) $ in Millions |
1 Months Ended |
---|---|
Jun. 15, 2012
USD ($)
| |
Commitments and Contingencies Disclosure [Abstract] | |
Milestone payment | $ 1 |
Description of royalty payment | Upon commercial sale of the drug, royalty payments of 2% of net sales will be due to FHCRC. |
X | ||||||||||
- Definition Description of royalty payment to related party. No definition available.
|
X | ||||||||||
- Definition The amount of milestone payment. No definition available.
|
X | ||||||||||
- References No definition available.
|